Summit Therapeutics, Inc. (SMMT)
13.29
+0.56
(+4.40%)
USD |
NASDAQ |
Aug 25, 14:46
Summit Therapeutics 1 Year Total Returns (Daily) : -51.41% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -51.41% |
| August 21, 2026 | -49.40% |
| August 20, 2026 | -51.95% |
| August 19, 2026 | -48.28% |
| August 18, 2026 | -51.24% |
| August 17, 2026 | -52.12% |
| August 14, 2026 | -49.53% |
| August 13, 2026 | -47.90% |
| August 12, 2026 | -41.21% |
| August 11, 2026 | -46.50% |
| August 10, 2026 | -48.12% |
| August 07, 2026 | -50.27% |
| August 06, 2026 | -52.52% |
| August 05, 2026 | -53.55% |
| August 04, 2026 | -53.07% |
| August 03, 2026 | -51.81% |
| July 31, 2026 | -50.63% |
| July 30, 2026 | -49.59% |
| July 29, 2026 | -52.13% |
| July 28, 2026 | -54.28% |
| July 27, 2026 | -54.29% |
| July 24, 2026 | -50.45% |
| July 23, 2026 | -46.52% |
| July 22, 2026 | -44.46% |
| July 21, 2026 | -44.46% |
| Date | Value |
|---|---|
| July 20, 2026 | -48.47% |
| July 17, 2026 | -50.02% |
| July 16, 2026 | -51.33% |
| July 15, 2026 | -38.14% |
| July 14, 2026 | -39.09% |
| July 13, 2026 | -38.80% |
| July 10, 2026 | -41.07% |
| July 09, 2026 | -37.43% |
| July 08, 2026 | -31.75% |
| July 07, 2026 | -29.77% |
| July 06, 2026 | -35.11% |
| July 02, 2026 | -31.83% |
| July 01, 2026 | -32.17% |
| June 30, 2026 | -31.53% |
| June 29, 2026 | -30.49% |
| June 26, 2026 | -34.29% |
| June 25, 2026 | -33.33% |
| June 24, 2026 | -31.88% |
| June 23, 2026 | -30.11% |
| June 22, 2026 | -30.54% |
| June 18, 2026 | -31.80% |
| June 17, 2026 | -29.12% |
| June 16, 2026 | -30.43% |
| June 15, 2026 | -28.56% |
| June 12, 2026 | -30.51% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| NovelStem International Corp. | -47.22% |
| Brainstorm Cell Therapeutics, Inc. | 54.99% |
| Kezar Life Sciences, Inc. | 79.56% |
| Protara Therapeutics, Inc. | 24.44% |
| Clene, Inc. | -21.64% |